CAMERON Associates
Home About Us Client News & Info Upcoming Client Events Contact Us Site Map
Select a Client

For more information please contact:
Al Palombo
212.554.5488
Al@cameronassoc.com

ReGen Biologics, Inc. (OTC BB: RGBI)
ReGen Biologics, Inc. (OTC: RGBI) is an orthopedic products company providing minimally invasive human implants and medical devices designed to facilitate the growth of new tissue to replace damaged or removed human soft tissue, ReGen has developed a proprietary type I collagen material as well as several tissue engineering processes that are protected by numerous U.S. and international  patents.  Although its technology is broadly applicable to most tissue areas, ReGen has focused its resources on orthopedics.  ReGen’s flagship product is the Collagen Meniscus Implant* (CMI) which is a Type I collagen implant designed for patients with an irreparable meniscus tear or loss of meniscus tissue, typically through an arthroscopic partial meniscectomy procedure. The purpose of the CMI is to assist patients to regain mobility and return to a more vigorous lifestyle, while forestalling or minimizing degenerative joint disease. 

December 5, 2007:
ReGen Biologics Introduces New Brand Name and Websites
- download word.doc (40 Kb) »
November 21, 2007:
ReGen Biologics Enters New Markets in Poland and South Africa
- download word.doc (40 Kb) »
September 25, 2007:
ReGen Biologics Receives NSE Letter from FDA, Proceeding with Next Steps to Gain U.S. Market Clearance
- download word.doc (40 Kb) »
July 9, 2007:
ReGen Biologics To Exhibit at 2007 AOSSM Annual Meeting
- download word.doc (40 Kb) »
June 26, 2007:
ReGen Biologics Responds to FDA Request for Additional Information on Pending 510(k)
- download word.doc (40 Kb) »
May 25, 2007:
ReGen Biologics to Launch Lateral CMIT at 6th Biennial ISAKOS Congress
- download word.doc (40 Kb) »
April 26, 2007:
ReGen Biologics Participates in 2007 AANA Annual Meeting
- download word.doc (40 Kb) »
April 5, 2007:
ReGen Biologics Closes $2.7 Million Private Placement
- download word.doc (40 Kb) »
March 6, 2007:
ReGen Biologics Closes Additional $3 Million Private Placement
- download word.doc (40 Kb) »
February 26, 2007:
ReGen Biologics Data Presented in San Diego
- download word.doc (40 Kb) »
February 6, 2007:
ReGen Biologics to Present at First Albany's 2nd Annual Orthopedics Conference on February 13, 2007
- download word.doc (40 Kb) »
February 5, 2007:
ReGen Biologics Participates in 2007 AAOS Annual Meeting
- download word.doc (40 Kb) »
December 4, 2006:
REGEN BIOLOGICS COMPLETES APPROXIMATELY $7 MILLION PRIVATE PLACEMENT
- download word.doc (40 Kb) »
November 13, 2006:
ReGen Biologics Announces Results of FDA Appeal
- download word.doc (40 Kb) »
November 7, 2006:
ReGen Biologics Announces New CMI Clinical Results
- download word.doc (40 Kb) »
 

Quality Investor Relations Since 1976
© 2003 Cameron Associates. All rights reserved.